Tabula Rasa Healthcare (TRHC) PT Raised to $7 at RBC Capital, 'Preannounces Better-Than-Expected Q4'

January 17, 2023 4:23 PM EST
Get Alerts TRHC Hot Sheet
Price: $10.50 --0%

Rating Summary:
    7 Buy, 9 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 17 | New: 17
Join SI Premium – FREE
(Updated - January 17, 2023 4:23 PM EST)

RBC Capital analyst Sean Dodge raised the price target on Tabula Rasa Healthcare (NASDAQ: TRHC) to $7.00 (from $6.00) while maintaining a Outperform rating.

The analyst comments "This morning, TRHC pre-announced Q4 revenue 5.1% above consensus, bringing the FY revenue growth target to ~15%. We view this as an encouraging update heading into '23, particularly when combined with (1) the also-recently-announced (after Q3 results/most recent guidance) commercial win that should drive incremental growth in '23 and (2) what appears to be a stabilizing/improving PACE enrollment growth rate YoY. Raising PT to $7 (from $6)."

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change, Hot Comments

Related Entities

RBC Capital